ArticleFrontiers in neuroscience2026
GLOBE: an explainable machine learning platform for preoperative prediction of thromboembolism and neurological deterioration in patients with glioma.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with glioma are at high risk of postoperative venous thromboembolism (VTE) and postoperative neurological deterioration (PND). Conventional clinical scoring systems have limited accuracy in predicting these perioperative risks. This study aimed to develop and validate machine-learning models for individualized preoperative prediction of postoperative VTE and PND in patients with glioma. Methods: A retrospective cohort of 427 patients with glioma was included. Patients were randomly divided into training and test sets at an 8:2 ratio using stratified random sampling. Multiple machine-learning algorithms were trained and evaluated. Model performance was assessed using the area under the curve (AUC), accuracy, sensitivity, specificity, calibration curves, and decision curve analysis. An online prediction platform was developed to facilitate individualized risk assessment. Results: Among 427 patients, postoperative VTE and PND occurred in 34 and 35%, respectively. For VTE prediction, the final Top-10 random forest model outperformed the Caprini score alone and achieved an AUC of 0.815 (95% CI, 0.720-0.910) in the held-out test set. Performance remained strong in the clinically significant VTE sensitivity analysis (AUC, 0.923; 95% CI, 0.847-0.998). SHAP analysis indicated that older age, elevated D-dimer and fibrin degradation products (FDP), as well as lower hemoglobin levels, were associated with increased predicted VTE risk. For PND prediction, the final Top-10 logistic regression model achieved an AUC of 0.741 (95% CI, 0.627-0.854). Older age, recurrent glioma, higher Caprini score, higher neutrophil percentage, and hypertension history tended to increase predicted PND risk. Models were deployed in the GLOBE web platform (https://gliomas.shinyapps.io/GLOBE/) for real-time preoperative risk prediction. Conclusion: We developed accurate, interpretable, and clinically meaningful preoperative prediction models for postoperative VTE and PND in patients with glioma. The GLOBE online prediction system translates these models into a practical tool for individualized perioperative risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.